BeStock  
Stocks › Biotechnology › BNTX

BioNTech BNTX

US equityMarket cap rank #505BiotechnologyInfectious Disease
$97.40 −$0.90 (-0.92%)
Market open · Oct 1, 1:20 pm ET · After hours $98.30 0.00%
Open$97.59
Prev close$98.30
Day range$97.13 – $99.41
Volume306.6K
Market cap$24.47B
P/E (TTM)–
Dividend yield–

BNTX Stock News

Headlines matching BioNTech or the BNTX ticker, most recent first.

  • BMO Capital Downgrades BioNTech(BNTX.US) to Hold Rating, Cuts Target Price to $105Market news · 8 Sep 2026
  • Goldman Sachs Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $127Market news · 4 Sep 2026
  • BioNTech(BNTX.US) 10% Shareholder Sells US$6.01 Million in Common StockMarket news · 29 Sep 2026
  • Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $115Market news · 28 Sep 2026
  • BioNTech(BNTX.US) 10% Shareholder Sells US$6.84 Million in Common StockMarket news · 25 Sep 2026
  • Wells Fargo Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $140Market news · 25 Sep 2026
  • CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $136Market news · 23 Sep 2026
  • UBS Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $135Market news · 17 Sep 2026
  • A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $135 to $140Market news · 16 Sep 2026
  • BofA Securities Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $122Market news · 15 Sep 2026
  • Evercore Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $130Market news · 6 Aug 2026
  • Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $115Market news · 5 Aug 2026
  • Citi Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $125Market news · 31 Aug 2026
  • CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $136Market news · 31 Aug 2026
  • BMO Capital Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $128Market news · 29 Aug 2026

Discussion

No comments yet — be the first to weigh in on BNTX.

Leave a comment

Scroll to Top